COMMUNIQUÉS West-GlobeNewswire

Jasper Therapeutics Reports Positive Data from 180mg Cohort in SPOTLIGHT Study of Briquilimab in Chronic Inducible Urticaria
14/06/2025
11 of 12 participants (92%) enrolled in the 180mg cohort achieved a complete response 12 of 12 participants (100%) in the 180mg cohort achieved a clinical response Tryptase levels below the lower limit of quantification [...]
SAFE - Lancement d’une réduction de capital non motivée par des pertes par voie de réduction de la valeur nominale des actions sous condition suspensive de la réalisation des opérations de regroupement d’actions
14/06/2025
Lancement d’une réduction de capital non motivée par des pertes par voie de réduction de la valeur nominale des actions sous condition suspensive de la réalisation des opérations de regroupement d’actions Fleurieux-sur- [...]
Avricore Grants Options
14/06/2025
VANCOUVER, British Columbia, June 14, 2025 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the " Company " or “ Avricore ”) today announces that the Company’s board of directors has approved the granting of stock [...]
Vaxart Announces Preliminary Results of Annual Meeting of Stockholders
13/06/2025
SOUTH SAN FRANCISCO, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based [...]
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13/06/2025
LEXINGTON, Mass., June 13, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to [...]
23andMe Reaches Agreement for Sale of Business to TTAM Research Institute Following Final Round of Bidding in Court-Approved Sale Process
13/06/2025
TTAM Commits to Comply with Company’s Privacy Policy and All Applicable Laws TTAM Commits to Adopting Additional Consumer Protections and Privacy Safeguards to Enhance Protections for Customer Data and Privacy No [...]
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13/06/2025
SAN FRANCISCO, June 13, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein [...]
KFSHRC Advances Smart Hospital Transformation through AI and Emerging Technologies
13/06/2025
RIYADH, Saudi Arabia, June 13, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) continues to redefine global healthcare through its Smart Hospital initiative, leveraging AI, [...]
MSP Recovery Law Firm Files Class Action Lawsuit Against Ralph Navarro and FYI Yachts for Alleged Fraud, Racketeering, and Consumer Abuse
13/06/2025
DEFENDANT RALPH NAVARRO/FYI YACHTS Class Action Lawsuit Filed Against RALPH NAVARRO and FYI YACHTS for Alleged Fraud, Racketeering, and Consumer Abuse MIAMI, June 13, 2025 (GLOBE NEWSWIRE) -- MSP Recovery Law Firm files [...]
Sunset Social Club Opens as West Hollywood’s First Luxury Cannabis Lounge for Members Only
13/06/2025
Curated 5,500-Square-Foot Venue Launches June 14 Across from Chateau Marmont with Premium Brands, Gourmet Experiences, and Hollywood Design Flair WEST HOLLYWOOD, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- In the heart of [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 23 - 2025
13/06/2025
Aggregated presentation by day and by market Statement of transactions in own shares from June 2nd to June 6th 2025 Name of the issuer Identity code of the issuer (Legal Entity Identifier) Day of the transaction [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 23 - 2025
13/06/2025
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 02 juin au 06 juin 2025 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code [...]
PolTREG Establishes U.S. Subsidiary Immuthera to Advance International Development Strategy
13/06/2025
PolTREG Establishes U.S. Subsidiary Immuthera to Advance International Development Strategy PolTREG established Immuthera ( https://immuthera.bio/ ) in Delaware to expand its presence in the U.S. market. A Pre-IND [...]
The Dental Medical Convergence Announces Featured Article and Podcast Interview on KevinMD Highlighting Dangers of Dental Infections
13/06/2025
Article and Podcast Interview to Alert the Public That Dental Infections Regularly Kill Eustis, Florida , June 13, 2025 (GLOBE NEWSWIRE) -- The Dental Medical Convergence , a nonprofit dedicated to educating the public [...]
Tiziana Life Sciences Expands Phase 2 Clinical Trial of Intranasal Foralumab with Commencement of First Patient Dosing at Weill Cornell Multiple Sclerosis Center
13/06/2025
NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development [...]
13171229 B.C. Ltd. and Launchit Solutions Inc. Announce Execution of Business Combination Agreement and Launchit’s Concurrent Financing
13/06/2025
VANCOUVER, British Columbia, June 13, 2025 (GLOBE NEWSWIRE) -- 1317229 B.C. Ltd. (“ 131 ” or the “ Company ”) and Launchit Solutions Inc. (“ Launchit ”) are pleased to announce that the Company, Launchit and 1001240330 [...]
Connect Biopharma Presents Data Supporting Rademikibart at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress
13/06/2025
– Rademikibart significantly improved lung function and asthma control in patients with eosinophilic-driven type 2 asthma – – Rademikibart reduced annualized exacerbations in patients with eosinophilic-driven type 2 [...]
InspireMD Announces CE Mark Approval for CGuard® Prime Embolic Prevention System (EPS) Under European MDR for the Prevention of Stroke
13/06/2025
MIAMI, June 13, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard ® Prime carotid stent system for the prevention of stroke, today announced the company has received CE Mark approval under [...]
GT Biopharma Appoints New Member to its Board of Directors
13/06/2025
SAN FRANCISCO, CALIFORNIA, June 13, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company [...]

Pages